SCHEMBL480560

SCHEMBL480560

CCOC(=O)c1ccc2c(c1)NC(=O)C2=C(Nc1ccc(C(C)(C)N)c(NS(C)(=O)=O)c1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.41
HPGD P15428 2/20 0.40
RECQL P46063 1/20 0.40
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
GAA P10253 2/20 0.37
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
LMNA P02545 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19133990 1.00 RXFP1 (0.41) RXFP1HPGDRECQLMAPK1ALDH1A1
SCHEMBL479891 0.92 HTT (0.41) HPGDMAPK1ALDH1A1HSD17B10KDM4E
SCHEMBL19133985 0.92 HTT (0.41) HPGDMAPK1ALDH1A1HSD17B10KDM4E
SCHEMBL2123987 0.88 RXFP1 (0.45) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL480445 0.87 RXFP1 (0.45) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL480689 0.87 RXFP1 (0.45) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL19133988 0.86 RXFP1 (0.44) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL480447 0.86 RXFP1 (0.44) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL2121050 0.86 RXFP1 (0.44) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL479819 0.86 RXFP1 (0.44) RXFP1MAPK1ALDH1A1HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF RXFP1 2731/4885HPGD 1807/4885RECQL 3659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.